{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:57:11Z","timestamp":1793451431366,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.peptides.2021.170666","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T15:58:47Z","timestamp":1632931127000},"page":"170666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"special_numbering":"C","title":["Chemical modifications to increase the therapeutic potential of antimicrobial peptides"],"prefix":"10.1016","volume":"146","author":[{"given":"Yajun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-2277","authenticated-orcid":false,"given":"Zhiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6870","key":"10.1016\/j.peptides.2021.170666_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"issue":"5820","key":"10.1016\/j.peptides.2021.170666_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/292246a0","article-title":"Sequence and specificity of two antibacterial proteins involved in insect immunity","volume":"292","author":"Steiner","year":"1981","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0015","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/S0021-9258(18)89110-4","article-title":"Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils","volume":"260","author":"Selsted","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.peptides.2021.170666_bib0020","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2021.170666_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-3588-4_1","article-title":"Antimicrobial peptides of multicellular organisms: my perspective","volume":"1117","author":"Zasloff","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"D1","key":"10.1016\/j.peptides.2021.170666_bib0030","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/092986711794088399","article-title":"Use of antimicrobial peptides against microbial biofilms: advantages and limits","volume":"18","author":"Batoni","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170666_bib0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7162","key":"10.1016\/j.peptides.2021.170666_bib0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.peptides.2021.170666_bib0050","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","article-title":"Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis","volume":"125","author":"Doring","year":"2012","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.peptides.2021.170666_bib0055","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.scib.2018.09.014","article-title":"Antimicrobial peptide LL-37 forms complex with bacterial DNA to facilitate blood translocation of bacterial DNA and aggravate ulcerative colitis","volume":"63","author":"Duan","year":"2018","journal-title":"Sci. Bull."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.immuni.2015.10.018","article-title":"Mitochondrial DNA-LL-37 complex promotes atherosclerosis by escaping from autophagic recognition","volume":"43","author":"Zhang","year":"2015","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0065","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.peptides.2021.170666_bib0070","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/exd.13314","article-title":"Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.peptides.2021.170666_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2017.01.004","article-title":"The dual role of cathelicidins in systemic inflammation","volume":"182","author":"Pinheiro da Silva","year":"2017","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0080","first-page":"56","article-title":"The treasure called antibiotics","volume":"14","author":"Adedeji","year":"2016","journal-title":"Ann. Ib. Postgrad. Med."},{"key":"10.1016\/j.peptides.2021.170666_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-981-13-3588-4_15","article-title":"Clinical application of AMPs","volume":"1117","author":"Costa","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7643","key":"10.1016\/j.peptides.2021.170666_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative Bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.peptides.2021.170666_bib0100","doi-asserted-by":"crossref","DOI":"10.1186\/2047-2994-3-32","article-title":"Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"3","author":"Nathwani","year":"2014","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.peptides.2021.170666_bib0105","series-title":"Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis","year":"2017"},{"issue":"12","key":"10.1016\/j.peptides.2021.170666_bib0110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.peptides.2021.170666_bib0115","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.24272\/j.issn.2095-8137.2019.062","article-title":"Antimicrobial peptides: new hope in the war against multidrug resistance","volume":"40","author":"Mwangi","year":"2019","journal-title":"Zool. Res."},{"issue":"423","key":"10.1016\/j.peptides.2021.170666_bib0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4044","article-title":"The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms","volume":"10","author":"de Breij","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.peptides.2021.170666_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-981-13-3588-4_11","article-title":"Selectivity of antimicrobial peptides: a complex interplay of multiple equilibria","volume":"1117","author":"Bobone","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.peptides.2021.170666_bib0135","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/AAC.00208-07","article-title":"Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens","volume":"51","author":"Beckloff","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2021.170666_bib0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-13-3588-4_13","article-title":"Application of synthetic molecular evolution to the discovery of antimicrobial peptides","volume":"1117","author":"Wimley","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.peptides.2021.170666_bib0145","series-title":"Antimicrobial Peptides: Basics for Clinical Application","author":"Matsuzaki","year":"2019"},{"key":"10.1016\/j.peptides.2021.170666_bib0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2741\/4461","article-title":"Antimicrobial peptides from frog skin: biodiversity and therapeutic promises","volume":"21","author":"Ladram","year":"2016","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bip.360370206","article-title":"Structure-activity studies on magainins and other host defense peptides","volume":"37","author":"Maloy","year":"1995","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/j.peptides.2021.170666_bib0160","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acs.jmedchem.5b01264","article-title":"A designed tryptophan- and lysine\/arginine-rich antimicrobial peptide with therapeutic potential for clinical antibiotic-resistant Candida albicans vaginitis","volume":"59","author":"Jin","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170666_bib0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1909585117","article-title":"The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection","author":"Mwangi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.peptides.2021.170666_bib0170","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bbamem.2006.04.006","article-title":"Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action","volume":"1758","author":"Chan","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.49.1.316-322.2005","article-title":"De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity","volume":"49","author":"Deslouches","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/psc.338","article-title":"Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives","volume":"7","author":"Haug","year":"2001","journal-title":"J. Pept. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0185","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/AAC.02218-12","article-title":"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens","volume":"57","author":"Deslouches","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2-3","key":"10.1016\/j.peptides.2021.170666_bib0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0014-5793(01)02648-5","article-title":"Optimization of the antimicrobial activity of magainin peptides by modification of charge","volume":"501","author":"Dathe","year":"2001","journal-title":"FEBS Lett."},{"issue":"Database issue","key":"10.1016\/j.peptides.2021.170666_bib0195","doi-asserted-by":"crossref","first-page":"D1108","DOI":"10.1093\/nar\/gkr1063","article-title":"DAMPD: a manually curated antimicrobial peptide database","volume":"40","author":"Seshadri Sundararajan","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2021.170666_bib0200","doi-asserted-by":"crossref","first-page":"24482","DOI":"10.1038\/srep24482","article-title":"DRAMP: a comprehensive data repository of antimicrobial peptides","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"issue":"D1","key":"10.1016\/j.peptides.2021.170666_bib0205","doi-asserted-by":"crossref","first-page":"D1094","DOI":"10.1093\/nar\/gkv1051","article-title":"CAMPR3: a database on sequences, structures and signatures of antimicrobial peptides","volume":"44","author":"Waghu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2021.170666_bib0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-981-13-3588-4_12","article-title":"Design of antimicrobial peptides: progress made with human cathelicidin LL-37","volume":"1117","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0215","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1039\/B316168B","article-title":"Synchrotron radiation circular dichroism spectroscopy of proteins and applications in structural and functional genomics","volume":"35","author":"Miles","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.peptides.2021.170666_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-13-3588-4_4","article-title":"The mechanisms of action of cationic antimicrobial peptides refined by novel concepts from biophysical investigations","volume":"1117","author":"Aisenbrey","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.peptides.2021.170666_bib0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-981-13-3588-4_7","article-title":"Antimicrobial and cell-penetrating peptides: how to understand two distinct functions despite similar physicochemical properties","volume":"1117","author":"Neundorf","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0235","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.peptides.2021.170666_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003217","article-title":"Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0245","doi-asserted-by":"crossref","first-page":"e22120","DOI":"10.1371\/journal.pone.0022120","article-title":"Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0250","doi-asserted-by":"crossref","first-page":"e72923","DOI":"10.1371\/journal.pone.0072923","article-title":"A small peptide with therapeutic potential for inflammatory acne vulgaris","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.peptides.2021.170666_bib0255","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2174\/138161211797416057","article-title":"Antimalarial peptides: the long and the short of it","volume":"17","author":"Bell","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"28","key":"10.1016\/j.peptides.2021.170666_bib0260","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.1021\/bi035948v","article-title":"Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides","volume":"43","author":"Dathe","year":"2004","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181748","article-title":"THPdb: Database of FDA-approved peptide and protein therapeutics","volume":"12","author":"Usmani","year":"2017","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.peptides.2021.170666_bib0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00467-013-2513-9","article-title":"The innate immune response during urinary tract infection and pyelonephritis","volume":"29","author":"Spencer","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0280","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1441","article-title":"The co-evolution of host cationic antimicrobial peptides and microbial resistance","volume":"4","author":"Peschel","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"issue":"6490","key":"10.1016\/j.peptides.2021.170666_bib0285","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau5480","article-title":"Antimicrobial peptides: application informed by evolution","volume":"368","author":"Lazzaro","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.peptides.2021.170666_bib0290","first-page":"139","article-title":"Enfuvirtide, the first fusion inhibitor to treat HIV infection","volume":"7","author":"Poveda","year":"2005","journal-title":"AIDS Rev."},{"issue":"16","key":"10.1016\/j.peptides.2021.170666_bib0295","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1517\/14656566.2010.522178","article-title":"Enfuvirtide: from basic investigations to current clinical use","volume":"11","author":"Joly","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.peptides.2021.170666_bib0300","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0305","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.peptides.2021.170666_bib0310","first-page":"6523","article-title":"Design and activity of a cyclic mini-beta-defensin analog: a novel antimicrobial tool","volume":"10","author":"Scudiero","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.peptides.2021.170666_bib0315","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1021\/jo500699m","article-title":"Fmoc-based synthesis of disulfide-rich cyclic peptides","volume":"79","author":"Cheneval","year":"2014","journal-title":"J. Org. Chem."},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0320","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071217","article-title":"Cyclic peptides as novel therapeutic microbicides: engineering of human defensin mimetics","volume":"22","author":"Falanga","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0325","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.bmc.2017.09.040","article-title":"Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study","volume":"26","author":"Monaim","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0330","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrmicro1273","article-title":"Bacteriocins: developing innate immunity for food","volume":"3","author":"Cotter","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.peptides.2021.170666_bib0335","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<326::AID-IJC7>3.0.CO;2-X","article-title":"Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines","volume":"83","author":"Brinckerhoff","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0340","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.vascn.2010.02.010","article-title":"To protect peptide pharmaceuticals against peptidases","volume":"61","author":"Rink","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"9","key":"10.1016\/j.peptides.2021.170666_bib0345","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00018-005-5536-y","article-title":"Temporins, anti-infective peptides with expanding properties","volume":"63","author":"Mangoni","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0350","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1021\/cr4006704","article-title":"The chemistry and biological activities of peptides from amphibian skin secretions","volume":"115","author":"Xu","year":"2015","journal-title":"Chem. Rev."},{"issue":"49","key":"10.1016\/j.peptides.2021.170666_bib0355","doi-asserted-by":"crossref","first-page":"16198","DOI":"10.1021\/jp106915c","article-title":"Influence of lysine N(epsilon)-trimethylation and lipid composition on the membrane activity of the cecropin A-melittin hybrid peptide CA(1-7)M(2-9)","volume":"114","author":"Teixeira","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0360","doi-asserted-by":"crossref","DOI":"10.3390\/biom8020019","article-title":"Improving the activity of trp-rich antimicrobial peptides by Arg\/Lys substitutions and changing the length of cationic residues","volume":"8","author":"Arias","year":"2018","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.peptides.2021.170666_bib0365","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","article-title":"Peptide and protein PEGylation: a review of problems and solutions","volume":"22","author":"Veronese","year":"2001","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0370","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0375","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0380","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.drudis.2017.02.001","article-title":"The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches","volume":"22","author":"Bednarska","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0385","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1039\/C5SC04392A","article-title":"Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides","volume":"7","author":"Moradi","year":"2016","journal-title":"Chem. Sci."},{"issue":"5","key":"10.1016\/j.peptides.2021.170666_bib0390","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1039\/C7SC00770A","article-title":"Releasable and traceless PEGylation of arginine-rich antimicrobial peptides","volume":"8","author":"Gong","year":"2017","journal-title":"Chem. Sci."},{"issue":"13","key":"10.1016\/j.peptides.2021.170666_bib0395","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","article-title":"Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding","volume":"121","author":"Hagedorn","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0400","first-page":"11","article-title":"D-amino acids in nature, agriculture and biomedicine","volume":"13","author":"Grishin","year":"2020","journal-title":"Front. Life Sci."},{"issue":"37","key":"10.1016\/j.peptides.2021.170666_bib0405","doi-asserted-by":"crossref","first-page":"33913","DOI":"10.1074\/jbc.M204928200","article-title":"The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers","volume":"277","author":"Papo","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0410","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbamem.2010.06.026","article-title":"Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of Piscidin 1","volume":"1798","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0415","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.bbamem.2007.02.024","article-title":"Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance","volume":"1768","author":"Jung","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0420","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1073\/pnas.92.8.3449","article-title":"Retro and retroenantio analogs of cecropin-melittin hybrids","volume":"92","author":"Merrifield","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.peptides.2021.170666_bib0425","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0006-2952(99)00259-2","article-title":"Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide","volume":"58","author":"Hong","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.peptides.2021.170666_bib0430","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1021\/ja0584875","article-title":"Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region","volume":"128","author":"Li","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.peptides.2021.170666_bib0435","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/psc.853","article-title":"Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin","volume":"13","author":"Mangoni","year":"2007","journal-title":"J. Pept. Sci."},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0440","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/138920371408131227171817","article-title":"A lesson from Bombinins H, mildly cationic diastereomeric antimicrobial peptides from Bombina skin","volume":"14","author":"Mangoni","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"issue":"12","key":"10.1016\/j.peptides.2021.170666_bib0445","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/S0968-0896(99)00247-3","article-title":"Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide","volume":"7","author":"Oh","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170666_bib0450","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biomaterials.2016.01.051","article-title":"One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model","volume":"85","author":"Rai","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0455","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/C7BM00069C","article-title":"Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility","volume":"5","author":"Wadhwani","year":"2017","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0460","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2010.11.024","article-title":"Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide","volume":"150","author":"Bi","year":"2011","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0465","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/138955712801264774","article-title":"Nanostructures as promising tools for delivery of antimicrobial peptides","volume":"12","author":"Brandelli","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"issue":"22","key":"10.1016\/j.peptides.2021.170666_bib0470","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1002\/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S","article-title":"Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science","volume":"40","author":"Niemeyer","year":"2001","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"8","key":"10.1016\/j.peptides.2021.170666_bib0475","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.peptides.2021.170666_bib0480","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1039\/C4CS00387J","article-title":"Cell surface-based sensing with metallic nanoparticles","volume":"44","author":"Jiang","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.peptides.2021.170666_bib0485","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acs.bioconjchem.7b00368","article-title":"Recent developments in antimicrobial-peptide-conjugated gold nanoparticles","volume":"28","author":"Rajchakit","year":"2017","journal-title":"Bioconjug. Chem."},{"issue":"37","key":"10.1016\/j.peptides.2021.170666_bib0490","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1039\/C7NR04062H","article-title":"Multivalent gold nanoparticle-peptide conjugates for targeting intracellular bacterial infections","volume":"9","author":"Chowdhury","year":"2017","journal-title":"Nanoscale"},{"issue":"19","key":"10.1016\/j.peptides.2021.170666_bib0495","doi-asserted-by":"crossref","first-page":"10410","DOI":"10.1021\/acs.chemrev.5b00193","article-title":"Gold nanomaterials at work in biomedicine","volume":"115","author":"Yang","year":"2015","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.peptides.2021.170666_bib0500","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0505","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13404-013-0120-y","article-title":"Optimizing the immobilization of gold nanoparticles on functionalized silicon surfaces: amine- vs thiol-terminated silane","volume":"46","author":"Ben Haddada","year":"2013","journal-title":"Gold Bull."},{"issue":"15","key":"10.1016\/j.peptides.2021.170666_bib0510","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1021\/la034209c","article-title":"Investigation into the interaction between surface-bound alkylamines and gold nanoparticles","volume":"19","author":"Kumar","year":"2003","journal-title":"Langmuir"},{"issue":"7","key":"10.1016\/j.peptides.2021.170666_bib0515","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nnano.2009.153","article-title":"Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent","volume":"4","author":"Liu","year":"2009","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0520","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1021\/acsnano.7b09109","article-title":"Self-assembling myristoylated human alpha-defensin 5 as a next-generation nanobiotics potentiates therapeutic efficacy in bacterial infection","volume":"12","author":"Lei","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.peptides.2021.170666_bib0530","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-981-13-3588-4_10","article-title":"Antimicrobial host defence peptides: immunomodulatory functions and translational prospects","volume":"1117","author":"van der Does","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.peptides.2021.170666_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170385","article-title":"Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy","volume":"133","author":"Abbasi Gharibkandi","year":"2020","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046259","article-title":"Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens","volume":"7","author":"Falciani","year":"2012","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.peptides.2021.170666_bib0545","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1021\/bi9619987","article-title":"Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes","volume":"36","author":"Wieprecht","year":"1997","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.peptides.2021.170666_bib0550","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2736(01)00429-1","article-title":"General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides","volume":"1558","author":"Dathe","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0555","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0005-2736(97)00051-5","article-title":"Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria","volume":"1327","author":"Matsuzaki","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"26","key":"10.1016\/j.peptides.2021.170666_bib0560","doi-asserted-by":"crossref","first-page":"17584","DOI":"10.1074\/jbc.M109.011650","article-title":"Boosting antimicrobial peptides by hydrophobic oligopeptide end tags","volume":"284","author":"Schmidtchen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0565","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.bbamem.2010.12.020","article-title":"Membrane selectivity by W-tagging of antimicrobial peptides","volume":"1808","author":"Schmidtchen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2021.170666_bib0570","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cis.2013.06.009","article-title":"Effect of hydrophobic modifications in antimicrobial peptides","volume":"205","author":"Schmidtchen","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"issue":"17","key":"10.1016\/j.peptides.2021.170666_bib0575","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1021\/ma201678r","article-title":"Water-soluble polypeptides with elongated, charged side chains adopt ultra-stable helical conformations","volume":"44","author":"Zhang","year":"2011","journal-title":"Macromolecules"},{"issue":"5","key":"10.1016\/j.peptides.2021.170666_bib0580","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/jm1012853","article-title":"Structure-activity relationship, conformational and biological studies of temporin L analogues","volume":"54","author":"Mangoni","year":"2011","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.peptides.2021.170666_bib0585","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/psc.2574","article-title":"The importance of being kinked: role of Pro residues in the selectivity of the helical antimicrobial peptide P5","volume":"19","author":"Bobone","year":"2013","journal-title":"J. Pept. Sci."},{"issue":"43","key":"10.1016\/j.peptides.2021.170666_bib0590","doi-asserted-by":"crossref","first-page":"12462","DOI":"10.1021\/jp507289w","article-title":"Peptides with the same composition, hydrophobicity, and hydrophobic moment bind to phospholipid bilayers with different affinities","volume":"118","author":"Cherry","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"53","key":"10.1016\/j.peptides.2021.170666_bib0595","doi-asserted-by":"crossref","first-page":"55042","DOI":"10.1074\/jbc.M408881200","article-title":"Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity","volume":"279","author":"Asthana","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.peptides.2021.170666_bib0600","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.peptides.2021.170666_bib0605","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/ph7040366","article-title":"\"specificity determinants\" improve therapeutic indices of two antimicrobial peptides piscidin 1 and dermaseptin s4 against the gram-negative pathogens Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"7","author":"Jiang","year":"2014","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0610","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cbdd.13058","article-title":"Role of positively charged residues on the polar and non-polar faces of amphipathic alpha-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens","volume":"91","author":"Jiang","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"1583","key":"10.1016\/j.peptides.2021.170666_bib0615","first-page":"251","article-title":"Experimental evolution of resistance to an antimicrobial peptide","volume":"273","author":"Perron","year":"2006","journal-title":"Proc. Biol. Sci."},{"issue":"1695","key":"10.1016\/j.peptides.2021.170666_bib0620","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0292","article-title":"Bacterial strategies of resistance to antimicrobial peptides","volume":"371","author":"Joo","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2021.170666_bib0625","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14712598.2017.1315402","article-title":"An overview of antimicrobial peptides and the latest advances in their development","volume":"17","author":"Sierra","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"10","key":"10.1016\/j.peptides.2021.170666_bib0630","doi-asserted-by":"crossref","first-page":"e76521","DOI":"10.1371\/journal.pone.0076521","article-title":"Comparing selection on S. aureus between antimicrobial peptides and common antibiotics","volume":"8","author":"Dobson","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.peptides.2021.170666_bib0635","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/dkw381","article-title":"Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides","volume":"72","author":"Kubicek-Sutherland","year":"2017","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:32:22Z","timestamp":1759311142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":127,"alternative-id":["S0196978121001741"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170666","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical modifications to increase the therapeutic potential of antimicrobial peptides","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170666"}}